More Hungarians Receiving Free Drugs
Hungary's Ministry of Finance has reported that the number of people receiving free medicines because of their low income in the first nine months of this year was 550,000, reports MTI Econews. In 1995, 3% of Hungary's population, or 300,000 people, were eligible to receive free medicines. The cost of providing them was equivalent to 20% of the medicines support budget of the health insurance fund.
The Ministry of Welfare defines those eligible to free medicines as those who pay more than 960 forint ($6.00) a month for medicines prescribed by a doctor, and who have a monthly wage of less than 9,600 forint if in a family or 14,400 forint for a single person.
The current system of drug price subsidies was due to be reviewed by the Ministry of Welfare on October 31, but the Ministry was expected to propose no radical reforms in the system, say reports.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze